NCT00484029View on ClinicalTrials.gov

Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Temporomandibular DisordersPainHeadaches
Interventions
DRUG

Nasal Carbon Dioxide

Nasal Carbon Dioxide

OTHER

Air

Air (Medical Grade)

Trial Locations (1)

98195

University of Washington, Department of Oral Medicine, Box 356370, Health Sciences Building, Seattle

All Listed Sponsors
lead

Capnia, Inc.

INDUSTRY

NCT00484029 - Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain | Biotech Hunter | Biotech Hunter